Meeting of the Advisory Committee on Immunization Practices, 79610-79611 [2024-22357]

Download as PDF 79610 Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices SECURITY CLASSIFICATION: Records–FTC), FTC–I–6 (Public Records–FTC). Unclassified. SYSTEM LOCATION: RECORD SOURCE CATEGORIES: Federal Trade Commission, 600 Pennsylvania Avenue NW, Washington, DC 20580. For other locations where records may be maintained or accessed, see Appendix III (Locations of FTC Buildings and Regional Offices), available on the FTC’s website at https://www.ftc.gov/about-ftc/foia/foiareading-rooms/privacy-act-systems and at 87 FR 57698 (Sept. 21, 2022). FTC employees and others who submit documents to the Commission. SYSTEM MANAGER(S): Office of the Secretary, Records Management Division, Federal Trade Commission, 600 Pennsylvania Avenue NW, Washington, DC 20580, email: SORNs@ftc.gov. AUTHORITY FOR MAINTENANCE OF THE SYSTEM: Federal Trade Commission Act, 15 U.S.C. 41 et seq. PURPOSE(S) OF THE SYSTEM: Records in this system may be disclosed to contractors in connection with document processing, storage, disposal and similar records management and retrieval activities. For other ways that the Privacy Act permits the FTC to use or disclose system records outside the agency, see Appendix I (Authorized Disclosures and Routine Uses Applicable to All FTC Privacy Act Systems of Records), available on the FTC’s website at https://www.ftc.gov/about-ftc/foia/foiareading-rooms/privacy-act-systems and at 83 FR 55541, 55542–55543 (Nov. 6, 2018). To provide staff with the ability to search for and access copies of agency documents needed for legal and economic research activities of the Commission (e.g., internal memoranda, economic reports, other agency work product); to provide FTC staff processing Freedom of Information Act or other disclosure requests with the ability to search for and access copies of potentially responsive documents outlining the actions and considerations of the Commission, individual Commissioners, and the staff; to provide the ability, once the automated system is fully implemented, to electronically manage the writing, editing, storage, retrieval and disposal of such documents (e.g., memoranda, correspondence), and to provide for additional document management functions, if any. POLICIES AND PRACTICES FOR STORAGE OF RECORDS: CATEGORIES OF INDIVIDUALS COVERED BY THE SYSTEM: Access is restricted to agency personnel and contractors whose responsibilities require access. Paper or other non-digital records are stored in secure offsite storage or lockable file cabinets or offices. Access to electronic records is controlled by ‘‘user ID’’ and password combination, and/or rolebased access controls, and/or other appropriate electronic access or network controls (e.g., firewalls). FTC buildings are guarded and monitored by security personnel, cameras, ID checks, and other physical security measures. Individuals who have written documents contained in Commission files, and other individuals whose names or other personally identifying data are used to search and retrieve documents from the system. CATEGORIES OF RECORDS IN THE SYSTEM: ddrumheller on DSK120RN23PROD with NOTICES1 ROUTINE USES OF RECORDS MAINTAINED IN THE SYSTEM, INCLUDING CATEGORIES OF USERS AND THE PURPOSES OF SUCH USES: Name of author and documents written by that individual; names or other data about other individuals by which documents in the system are searched and retrieved; finding aids or document indexes. Records in this system may duplicate records included in other FTC systems of records. See, e.g., FTC–I–1 (Nonpublic Investigational and Other Nonpublic Legal Program VerDate Sep<11>2014 17:51 Sep 27, 2024 Jkt 262001 Older records are stored on electronic and non-electronic formats. The system also comprises one or more structured databases using commercial software applications to search, retrieve, and manage records stored electronically. POLICIES AND PRACTICES FOR RETRIEVAL OF RECORDS: Indexed by author of the document, or other data fields or codes. POLICIES AND PRACTICES FOR RETENTION AND DISPOSAL OF RECORDS: on the FTC’s website at https:// www.ftc.gov/about-ftc/foia/foia-readingrooms/privacy-act-systems and at 73 FR 33592, 33634 (June 12, 2008). CONTESTING RECORD PROCEDURES: See § 4.13 of the FTC’s Rules of Practice, 16 CFR 4.13. For additional guidance, see also Appendix II (How to Make A Privacy Act Request), available on the FTC’s website at https:// www.ftc.gov/about-ftc/foia/foia-readingrooms/privacy-act-systems at 73 FR 33592, 33634 (June 12, 2008). NOTIFICATION PROCEDURES: See § 4.13 of the FTC’s Rules of Practice, 16 CFR 4.13. For additional guidance, see also Appendix II (How to Make A Privacy Act Request), available on the FTC’s website at https:// www.ftc.gov/about-ftc/foia/foia-readingrooms/privacy-act-systems at 73 FR 33592, 33634 (June 12, 2008). EXEMPTIONS PROMULGATED FOR THE SYSTEM: Records contained in this system that have been placed on the FTC public record are available upon request or, where applicable, made available online. See FTC–I–6 (Public Records– FTC). However, pursuant to 5 U.S.C. 552a(k)(2), records in this system, which reflect records that are contained in other systems of records that are designated as exempt, are exempt from the requirements of subsections (c)(3), (d), (e)(1), (e)(4)(G), (H), (I), and (f) of 5 U.S.C. 552a. See § 4.13(m) of the FTC Rules of Practice, 16 CFR 4.13(m). HISTORY: Records are retained and destroyed in accordance with schedules and procedures issued or approved by the National Archives and Records Administration. 87 FR 964–974 (January 7, 2022) 73 FR 33591–33634 (June 12, 2008). * * * * * ADMINISTRATIVE, TECHNICAL, AND PHYSICAL SAFEGUARDS: [FR Doc. 2024–22391 Filed 9–27–24; 8:45 am] RECORD ACCESS PROCEDURES: See § 4.13 of the FTC’s Rules of Practice, 16 CFR 4.13. For additional guidance, see also Appendix II (How to Make A Privacy Act Request), available PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 Joel Christie, Acting Secretary. BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2024–0072] Meeting of the Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice and request for comment. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and SUMMARY: E:\FR\FM\30SEN1.SGM 30SEN1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment. DATES: The meeting will be held on October 23, 2024, from 8 a.m. to 5:30 p.m., EDT and October 24, 2024, from 8 a.m. to 5:30 p.m., EDT, (times subject to change); see the ACIP website for updates: https://www.cdc.gov/vaccines/ acip/). Written comments must be received between October 4–18, 2024. ADDRESSES: You may submit comments, identified by Docket No. CDC–2024– 0072, by either of the methods listed below. CDC does not accept comments by email. • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Ms. Stephanie Thomas, ACIP Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24–8, Atlanta, Georgia 30329–4027. Attn: Docket No. CDC– 2024–0072. Instructions: All submissions received must include the Agency name and docket number. All relevant comments received in conformance with the https://www.regulations.gov suitability policy will be posted without change to https://www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. The meeting will be webcast live via the World Wide Web. The webcast link can be found on the ACIP website at https://www.cdc.gov/vaccines/acip/ index.html. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management Specialist, Advisory Committee on Immunization Practices, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24–8, Atlanta, Georgia 30329–4027. Telephone: (404) 639–8836; Email: ACIP@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Advisory Committee on Immunization Practices (ACIP) is charged with advising the Director, Centers for Disease Control and Prevention (CDC), on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the VerDate Sep<11>2014 17:51 Sep 27, 2024 Jkt 262001 Vaccines for Children program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under applicable provisions of the Affordable Care Act and Section 2713 of the Public Health Service Act, immunization recommendations of ACIP that have been approved by the Director, CDC, and appear on CDC immunization schedules generally must be covered by applicable health plans. Matters to be Considered: The agenda will include discussions on chikungunya vaccines, COVID–19 vaccines, cytomegalovirus (CMV) vaccine, Human papillomavirus (HPV) vaccines, influenza vaccines, meningococcal vaccines, mpox vaccines, pneumococcal vaccines, Respiratory Syncytial Virus (RSV) vaccines for adults, RSV vaccines for maternal and pediatric populations, and the adult and child/adolescent immunization schedules. Recommendation votes are scheduled for COVID–19 vaccines, meningococcal vaccines, pneumococcal vaccines, RSV vaccines for adults, and the adult and child/adolescent immunization schedules. A Vaccines for Children (VFC) vote is scheduled for influenza vaccines and meningococcal vaccines. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda, visit https:// www.cdc.gov/vaccines/acip/meetings/ index.html. Meeting Information: The meeting will be webcast live via the World Wide Web. For more information on ACIP, please visit the ACIP website: https:// www.cdc.gov/vaccines/acip/. Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ PO 00000 Frm 00111 Fmt 4703 Sfmt 9990 79611 near-duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. Written Public Comment: The docket will be opened to receive written comments on October 4–18, 2024. Written comments must be received by October 18, 2024. Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes, including all votes relevant to the ACIP’s Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. Procedure for Oral Public Comment: All persons interested in making an oral public comment at the October 23–24, 2024, ACIP meeting must submit a request at https://www.cdc.gov/ vaccines/acip/meetings/ between October 4–18, 2024, and no later than 11:59 p.m., EDT, October 18, 2024, according to the instructions provided. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by October 21, 2024. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to three minutes, and each speaker may speak only once per meeting. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–22357 Filed 9–27–24; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\30SEN1.SGM 30SEN1

Agencies

[Federal Register Volume 89, Number 189 (Monday, September 30, 2024)]
[Notices]
[Pages 79610-79611]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22357]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2024-0072]


Meeting of the Advisory Committee on Immunization Practices

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and

[[Page 79611]]

Prevention (CDC) announces the following meeting of the Advisory 
Committee on Immunization Practices (ACIP). This meeting is open to the 
public. Time will be available for public comment.

DATES: The meeting will be held on October 23, 2024, from 8 a.m. to 
5:30 p.m., EDT and October 24, 2024, from 8 a.m. to 5:30 p.m., EDT, 
(times subject to change); see the ACIP website for updates: https://www.cdc.gov/vaccines/acip/).
    Written comments must be received between October 4-18, 2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0072, by either of the methods listed below. CDC does not accept 
comments by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Ms. Stephanie Thomas, ACIP Meeting, Centers for 
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, 
Atlanta, Georgia 30329-4027. Attn: Docket No. CDC-2024-0072.
    Instructions: All submissions received must include the Agency name 
and docket number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.
    The meeting will be webcast live via the World Wide Web. The 
webcast link can be found on the ACIP website at https://www.cdc.gov/vaccines/acip/.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management 
Specialist, Advisory Committee on Immunization Practices, National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-8836; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Committee on Immunization Practices (ACIP) is 
charged with advising the Director, Centers for Disease Control and 
Prevention (CDC), on the use of immunizing agents. In addition, under 
42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children program, along with schedules regarding dosing interval, 
dosage, and contraindications to administration of vaccines. Further, 
under applicable provisions of the Affordable Care Act and Section 2713 
of the Public Health Service Act, immunization recommendations of ACIP 
that have been approved by the Director, CDC, and appear on CDC 
immunization schedules generally must be covered by applicable health 
plans.
    Matters to be Considered: The agenda will include discussions on 
chikungunya vaccines, COVID-19 vaccines, cytomegalovirus (CMV) vaccine, 
Human papillomavirus (HPV) vaccines, influenza vaccines, meningococcal 
vaccines, mpox vaccines, pneumococcal vaccines, Respiratory Syncytial 
Virus (RSV) vaccines for adults, RSV vaccines for maternal and 
pediatric populations, and the adult and child/adolescent immunization 
schedules. Recommendation votes are scheduled for COVID-19 vaccines, 
meningococcal vaccines, pneumococcal vaccines, RSV vaccines for adults, 
and the adult and child/adolescent immunization schedules. A Vaccines 
for Children (VFC) vote is scheduled for influenza vaccines and 
meningococcal vaccines. Agenda items are subject to change as 
priorities dictate. For more information on the meeting agenda, visit 
https://www.cdc.gov/vaccines/acip/meetings/.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web. For more information on ACIP, please visit the ACIP website: 
https://www.cdc.gov/vaccines/acip/.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near-duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    Written Public Comment: The docket will be opened to receive 
written comments on October 4-18, 2024. Written comments must be 
received by October 18, 2024.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes, including all votes relevant to the ACIP's 
Affordable Care Act and Vaccines for Children Program roles. Priority 
will be given to individuals who submit a request to make an oral 
public comment before the meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the October 23-24, 2024, ACIP meeting must 
submit a request at https://www.cdc.gov/vaccines/acip/meetings/ between October 4-18, 2024, and no later than 11:59 p.m., 
EDT, October 18, 2024, according to the instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by October 21, 2024. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to three minutes, and each 
speaker may speak only once per meeting.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-22357 Filed 9-27-24; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.